Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.01. | Lifecare ASA: Financial calendar | - | Oslo Børs | ||
14.01. | Lifecare ASA: LIFE Fivefold improvement of sensor chemistry sensitivity | 3 | Oslo Børs | ||
13.11.24 | LIFE: Lifecare ASA Q3 2024 | 3 | Oslo Børs | ||
05.11.24 | Lifecare ASA Q3 2024 presentation | 3 | Oslo Børs | ||
29.10.24 | Lifecare ASA: Lifecare - Sanofi Product Development Agreement Update | 22 | Oslo Børs | ||
22.10.24 | Lifecare ASA listed on Euronext Oslo Børs | 2 | Oslo Børs | ||
21.10.24 | Nasdaq Stockholm AB: Admission to trading of Lifecare ASA on First North NOK | 204 | GlobeNewswire | Nasdaq Stockholm AB has admitted Lifecare ASA shares to trading on First North
NOK, with effect from October 22, 2024.
The shares will be traded on the First North NOK segment.
Short name: LIFEo... ► Artikel lesen | |
LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
21.10.24 | LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved | 1 | Oslo Børs | ||
18.10.24 | Lifecare ASA: Share capital increase registered | 1 | Oslo Børs | ||
15.10.24 | Lifecare ASA: Last day of application period | 1 | Oslo Børs | ||
14.10.24 | Lifecare ASA: Lifecare presentation at the Diabetes Technology Meeting 2024. | 2 | Oslo Børs | ||
14.10.24 | Lifecare ASA: Application deadline for applicants using Nordnet webservice | 3 | Oslo Børs | ||
10.10.24 | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
10.10.24 | Lifecare ASA: LIFE Study protocol has been finalized for submission to regulatory authorities | 1 | Oslo Børs | ||
08.10.24 | Lifecare ASA: Launch of public retail offering and commencement of application period | 1 | Oslo Børs | ||
08.10.24 | Lifecare ASA: LIFE Longevity trial: Biopsy and bacteriological examination confirm no unexpected foreign body reactions after removal of implant | 2 | Oslo Børs | ||
04.10.24 | Lifecare ASA: Approval and publication of prospectus | 1 | Oslo Børs | ||
03.10.24 | Lifecare ASA: OSLO BØRS - TRADING RESUMPTION WARRANTS | 6 | Oslo Børs | ||
02.10.24 | Lifecare ASA First successful production based on automatization of critical processes | 2 | Oslo Børs | ||
01.10.24 | Lifecare ASA: OSLO BØRS - TRADING SUSPENSION WARRANTS | 2 | Oslo Børs |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ROKU | 79,37 | -1,34 % | Roku Stock Sees RS Rating Climb To 79 | ||
SERNOVA | 0,133 | +0,68 % | Sernova (TSE:SVA) Sets New 12-Month Low - Here's What Happened | ||
BOSTON SCIENTIFIC | 97,00 | -0,51 % | Minimales Kursplus bei der Boston Scientific-Aktie (96,0998 €) | Der Kurs der dem Anteilsschein von Boston Scientific kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Papier 98,73 US-Dollar. Der Kurs der Aktie von Boston Scientific zeigt sich gegenwärtig... ► Artikel lesen | |
PAUL HARTMANN | 222,00 | -1,77 % | Paul Hartmann: Jedes Quartal die Prognose erhöht | Mit Aktien von Medizintechnikunternehmen war auch 2024 kaum etwas zu verdienen. Bekannte Titel wie Carl Zeiss Meditec, Stratec und Sartorius sorgten in den vergangenen zwölf Monaten sogar für herbe... ► Artikel lesen | |
ADDLIFE | 12,560 | +0,72 % | AddLife AB: Interim Report 1 January - 30 September 2024 | Organic growth and stable margin while profitability improvement initiatives are progressing
"Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker... ► Artikel lesen | |
EMBECTA | 18,000 | -2,17 % | Embecta Corp.: embecta to Report Fiscal First Quarter 2025 Financial Results | ||
R1 RCM | 13,400 | 0,00 % | R1 RCM Inc. (RCM): Driving Strong Revenue Growth with AI-Driven Solutions and Strategic Partnerships in Healthcare | ||
ENOVIS | 45,000 | 0,00 % | Enovis Corporation: Enovis Announces Leadership Change to International Surgical Business | Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin... ► Artikel lesen | |
SYSMEX | 17,800 | -5,32 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
PULMONX | 5,850 | 0,00 % | Pulmonx Corp - 10-Q, Quarterly Report | ||
KANGJI MEDICAL | 0,750 | +2,04 % | KANGJI MEDICAL (09997): NEXT DAY DISCLOSURE RETURN | ||
SI-BONE | 16,200 | +1,89 % | SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 | Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation | Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the "Company") announces release of a benefits plan to... ► Artikel lesen | |
KOOTH | 2,000 | -0,99 % | TRADING UPDATES: Kooth eyes top-end profit, while IQE sees sales beat | ||
PEIJIA MEDICAL | 0,450 | +1,35 % | Peijia Medical Announces 2024 Interim Results | HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen |